Thomas Sanford

Xinrui Song, Xuanang Xu, Sheng Xu et al.

In this work, we propose to explicitly use the landmarks of prostate to guide the MR-TRUS image registration. We first train a deep neural network to automatically localize a set of meaningful landmarks, and then directly generate the affine registration matrix from the location of these landmarks. For landmark localization, instead of directly training a network to predict the landmark coordinates, we propose to regress a full-resolution distance map of the landmark, which is demonstrated effective in avoiding statistical bias to unsatisfactory performance and thus improving performance. We then use the predicted landmarks to generate the affine transformation matrix, which outperforms the clinicians' manual rigid registration by a significant margin in terms of TRE.

Xuan Qi, Dominic Labella, Thomas Sanford et al.

We tackle atypical versus normal mitosis classification in the MIDOG 2025 challenge using EfficientViT-L2, a hybrid CNN--ViT architecture optimized for accuracy and efficiency. A unified dataset of 13,938 nuclei from seven cancer types (MIDOG++ and AMi-Br) was used, with atypical mitoses comprising ~15. To assess domain generalization, we applied leave-one-cancer-type-out cross-validation with 5-fold ensembles, using stain-deconvolution for image augmentation. For challenge submissions, we trained an ensemble with the same 5-fold split but on all cancer types. In the preliminary evaluation phase, this model achieved balanced accuracy of 0.859, ROC AUC of 0.942, and raw accuracy of 0.85, demonstrating competitive and well-balanced performance across metrics.